231 results
Page 4 of 12
6-K
hdp9 717ejdgk
21 Dec 22
Current report (foreign)
6:01am
6-K
17lez0
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
8cn1t tt2
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
ubibr
8 Dec 22
Current report (foreign)
6:46am
6-K
o8ycmjuxyqsrojy4
4 Nov 22
Current report (foreign)
6:01am
6-K
xhw6r3mi
27 Oct 22
Current report (foreign)
6:01am
6-K
EX-99.1
ezhz jyemrhprd
27 Oct 22
Current report (foreign)
6:01am
6-K
v5b1x
14 Oct 22
Current report (foreign)
7:36am
6-K
honvhr7l7i4p
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
rfyt3
23 Aug 22
Current report (foreign)
6:13am
6-K
EX-99.1
72j1k
4 Aug 22
Current report (foreign)
6:07am
6-K
gfkelbf661 j53d2m
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
vnsxufnypt0hqnew8
28 Jul 22
Current report (foreign)
6:09am
6-K
o35u 3ig19
28 Jul 22
Current report (foreign)
6:09am
6-K
ycr8mksvy7iuq4r7ls6w
11 Jul 22
Current report (foreign)
6:05am
S-8
EX-99.1
29c14z5p
29 Jun 22
Registration of securities for employees
6:13am
6-K
57q35y 4oe98vg35sg
29 Jun 22
Current report (foreign)
6:02am
6-K
v29g5q3
24 Jun 22
Current report (foreign)
6:08am
6-K
upi0e0o5a37
10 Jun 22
Current report (foreign)
6:00am